{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T06:32:23Z","timestamp":1773124343008,"version":"3.50.1"},"reference-count":32,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IDR"],"DOI":"10.2147\/idr.s572423","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T17:35:11Z","timestamp":1773077711000},"page":"1-11","source":"Crossref","is-referenced-by-count":0,"title":["Interim Effectiveness and Safety of Prolonged Bedaquiline Use in Comparison to Standard 24-Week Treatment for MDR-TB: A Multicenter Cohort Study in China"],"prefix":"10.2147","volume":"Volume 19","author":[{"given":"Xinyang","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengqiu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3769-6852","authenticated-orcid":true,"given":"Yuhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Pei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guihui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aidi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingtao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2026,3]]},"reference":[{"key":"ref1","unstructured":"Global tuberculosis report 2022. Geneva: World Health Organization; 2022."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.tube.2018.04.008","volume":"111","author":"Liu","year":"2018","journal-title":"Tuberculosis"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"222","DOI":"10.4103\/0976-500X.136121","volume":"5","author":"Xavier","year":"2014","journal-title":"J Pharmacol Pharmacother"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S2213-2600(19)30366-2","volume":"7","author":"Tweed","year":"2019","journal-title":"Lancet Respir Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/S2213-2600(19)30363-7","volume":"7","author":"McKenna","year":"2019","journal-title":"Lancet Respir Med"},{"key":"ref6","unstructured":"WHO consolidated guidelines on drug-resistant tuberculosis treatment. Geneva: World Health Organization; 2020."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1056\/NEJMoa1313865","volume":"371","author":"Diacon","year":"2014","journal-title":"N Engl J Med"},{"key":"ref8","unstructured":"World Health Organization. The Use of Bedaquiline in the Treatment of Multidrug-Resistant Tuberculosis: Interim Policy Guidance. World Health Organization; 2013."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1056\/NEJMoa1901814","volume":"382","author":"Conradie","year":"2020","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1093\/cid\/ciae601","volume":"81","author":"Khan","year":"2025","journal-title":"Clin Infect Dis"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"ofac372","DOI":"10.1093\/ofid\/ofac372","volume":"9","author":"van Beek","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"ref12","volume":"49","author":"Guglielmetti","year":"2017","journal-title":"Eur Respir J"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1186\/s12916-024-03633-3","volume":"22","author":"Song","year":"2024","journal-title":"BMC Med"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"e0009725","DOI":"10.1128\/spectrum.00097-25","volume":"13","author":"Yu","year":"2025","journal-title":"Microbiol Spectr"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"5055","DOI":"10.2147\/IDR.S419996","volume":"16","author":"Ke","year":"2023","journal-title":"Infect Drug Resist"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1164\/rccm.202211-2125OC","volume":"207","author":"Trevisi","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"00685","DOI":"10.1183\/23120541.00685-2021","volume":"8","author":"Zhurkin","year":"2022","journal-title":"ERJ Open Res"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1701552","DOI":"10.1183\/13993003.01552-2017","volume":"50","author":"Furin","year":"2017","journal-title":"Eur Respir J"},{"key":"ref19","unstructured":"Frequently asked questions about the use of bedaquiline according to the WHO guidelines and evidence from its early use in selected countries. 2017. Available from: https:\/\/www.who.int\/docs\/default-source\/documents\/tuberculosis\/faqs-bedaquiline.pdf?sfvrsn=ab0053b6_2. Accessed March 3, 2026."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s40121-021-00396-9","volume":"10","author":"Shi","year":"2021","journal-title":"Infect Dis Ther"},{"key":"ref21","unstructured":"Companion Handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis. Geneva: World Health Organization; 2014."},{"key":"ref22","unstructured":"U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases, AIDS Do. Division of AIDS (DAIDS) table for grading the severity of adult and pediatric adverse events, corrected version 2.1. Bethesda: National Institutes of Health; 2017. Available from: https:\/\/rsc.niaid.nih.gov\/sites\/default\/files\/daidsgradingcorrectedv21.pdf. Accessed March 3, 2026."},{"key":"ref23","unstructured":"Global tuberculosis report 2024. Geneva: World Health Organization; 2024."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1093\/cid\/ciz914","volume":"71","author":"Mase","year":"2020","journal-title":"Clin Infect Dis"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jinf.2018.08.003","volume":"78","author":"Borisov","year":"2019","journal-title":"J Infect"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1016\/S2213-2600(18)30453-3","volume":"6","author":"Yates","year":"2018","journal-title":"Lancet Respir Med"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1801528","DOI":"10.1183\/13993003.01528-2018","volume":"52","author":"Ndjeka","year":"2018","journal-title":"Eur Respir J"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"102522","DOI":"10.1016\/j.jiph.2024.102522","volume":"17","author":"Khan","year":"2024","journal-title":"J Infect Public Health"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00010-2015","volume":"1","author":"D\u2019Ambrosio","year":"2015","journal-title":"ERJ Open Res"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ijid.2014.12.012","volume":"32","author":"Lessem","year":"2015","journal-title":"Int J Infect Dis"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1700387","DOI":"10.1183\/13993003.00387-2017","volume":"49","author":"Borisov","year":"2017","journal-title":"Eur Respir J"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1023704","DOI":"10.3389\/fphar.2022.1023704","volume":"13","author":"Nguyen","year":"2022","journal-title":"Front Pharmacol"}],"container-title":["Infection and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/article\/download\/112860","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/article\/download\/112860","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T17:35:14Z","timestamp":1773077714000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/interim-effectiveness-and-safety-of-prolonged-bedaquiline-use-in-compa-peer-reviewed-fulltext-article-IDR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":32,"URL":"https:\/\/doi.org\/10.2147\/idr.s572423","relation":{},"ISSN":["1178-6973"],"issn-type":[{"value":"1178-6973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]}}}